- Home
- USM vs CORT Comparison
USM vs CORT Comparison
Compare USM & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USM
- CORT
- Stock Information
- Founded
- USM 1983
- CORT 1998
- Country
- USM United States
- CORT United States
- Employees
- USM N/A
- CORT N/A
- Industry
- USM Telecommunications Equipment
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- USM Telecommunications
- CORT Health Care
- Exchange
- USM Nasdaq
- CORT Nasdaq
- Market Cap
- USM 5.5B
- CORT 5.6B
- IPO Year
- USM 1988
- CORT N/A
- Fundamental
- Price
- USM $64.00
- CORT $55.31
- Analyst Decision
- USM Buy
- CORT Strong Buy
- Analyst Count
- USM 3
- CORT 4
- Target Price
- USM $80.00
- CORT $75.25
- AVG Volume (30 Days)
- USM 106.7K
- CORT 791.4K
- Earning Date
- USM 02-14-2025
- CORT 02-13-2025
- Dividend Yield
- USM N/A
- CORT N/A
- EPS Growth
- USM N/A
- CORT 57.97
- EPS
- USM N/A
- CORT 1.26
- Revenue
- USM $3,799,000,000.00
- CORT $628,555,000.00
- Revenue This Year
- USM N/A
- CORT $46.29
- Revenue Next Year
- USM N/A
- CORT $17.09
- P/E Ratio
- USM N/A
- CORT $43.87
- Revenue Growth
- USM N/A
- CORT 39.67
- 52 Week Low
- USM $32.01
- CORT $20.84
- 52 Week High
- USM $68.31
- CORT $62.22
- Technical
- Relative Strength Index (RSI)
- USM 59.65
- CORT 58.22
- Support Level
- USM $61.70
- CORT $49.00
- Resistance Level
- USM $64.04
- CORT $52.17
- Average True Range (ATR)
- USM 1.47
- CORT 1.76
- MACD
- USM 0.15
- CORT 0.52
- Stochastic Oscillator
- USM 87.61
- CORT 99.21
About USM United States Cellular Corporation
us Cellular is a regional wireless carrier that serves about 4.5 million customers spread across four major geographic clusters: the Midwest, mid-Atlantic, New England, and the Pacific Northwest. These service territories encompass a total population of about 32 million people. The vast majority of the markets the firm serves are rural or second/third-tier cities, with only the greater Milwaukee and Oklahoma City regions boasting populations greater than 1 million. us Cellular also owns a 5.5% stake in Verizon Wireless' Los Angeles operations and, unlike its wireless carrier peers, owns most of its own towers. The firm has agreed to sell its wireless operations and 30% of its wireless spectrum licenses to T-Mobile, a transaction that it expects to close in mid-2025.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.